Hemagglutinin-neuramidase inhibitor (Grand Pharmaceutical Group/Griffith University)

N/A

Report date: 2025/02/08 16:10:33
NME

Base Information

Drug NameHemagglutinin-neuramidase inhibitor (Grand Pharmaceutical Group/Griffith University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuraminidase inhibitorsInfluenza virus hemagglutinin glycoproteins inhibitors
TargetsNeuraminidaseInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsParamyxoviridae Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGriffith University
China Registration ClassN/A

Develop Information

Active CompaniesGriffith UniversityGrand Medical Pty LtdGrand Pharmaceutical （China） Co Ltd
Inactive CompaniesN/A
Active IndicationsParamyxoviridae Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A